IPP Bureau

Torrent Pharmaceuticals gets Form 483 with 5 observations for Indrad facility
Torrent Pharmaceuticals gets Form 483 with 5 observations for Indrad facility

By IPP Bureau - June 13, 2024

There was no observation related to data integrity reported

Pfizer updates on Phase 3 study of investigational gene therapy for ambulatory boys with Duchenne Muscular Dystrophy
Pfizer updates on Phase 3 study of investigational gene therapy for ambulatory boys with Duchenne Muscular Dystrophy

By IPP Bureau - June 13, 2024

The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment

Kardium announces US$ 104 million in new financing for innovative Atrial Fibrillation Treatment
Kardium announces US$ 104 million in new financing for innovative Atrial Fibrillation Treatment

By IPP Bureau - June 13, 2024

Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners

Lilly's tirzepatide was superior to placebo for MASH resolution
Lilly's tirzepatide was superior to placebo for MASH resolution

By IPP Bureau - June 13, 2024

SYNERGY-NASH results were presented at the European Association for the Study of the Liver Congress 2024 and simultaneously published in The New England Journal of Medicine

Glenmark receives ANDA approval for Esomeprazole Magnesium Delayed-Release capsules
Glenmark receives ANDA approval for Esomeprazole Magnesium Delayed-Release capsules

By IPP Bureau - June 12, 2024

Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace

IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol
IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol

By IPP Bureau - June 12, 2024

EDQM has also issued a Certificate of Suitability for Allopurino

Schneider Electric launches EcoStruxure for life science segment
Schneider Electric launches EcoStruxure for life science segment

By IPP Bureau - June 11, 2024

Accelerating sustainability in Indian pharma industry

Honeywell introduces batch historian to digitalize manufacturing operations
Honeywell introduces batch historian to digitalize manufacturing operations

By IPP Bureau - June 11, 2024

New software solution helps manufacturers digitalize and gain insights from data to increase efficiency

Abbott wins CE mark for dual-chamber leadless pacemaker
Abbott wins CE mark for dual-chamber leadless pacemaker

By IPP Bureau - June 11, 2024

Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers

J P Nadda takes charge as India's Health Minister
J P Nadda takes charge as India's Health Minister

By IPP Bureau - June 11, 2024

Nadda also interacted with senior officials of the Union Health Ministry after taking charge where he was briefed about the ongoing projects

Anupriya Patel takes charge as Minister of State in the Ministry of Health & Family Welfare
Anupriya Patel takes charge as Minister of State in the Ministry of Health & Family Welfare

By IPP Bureau - June 11, 2024

Patel has served in various capacities, from being a Member of the Uttar Pradesh Legislative Assembly to her recent role as Union Minister of State in the Ministry of Commerce and Industry

Prataprao Ganpatrao Jadhav takes charge as Minister of State in the Ministry of Health & Family Welfare
Prataprao Ganpatrao Jadhav takes charge as Minister of State in the Ministry of Health & Family Welfare

By IPP Bureau - June 11, 2024

Prior to taking charge at the Union Health Ministry, Jadhav planted a sapling at his residence

Fischer Medical Venture and BluSim Tech partner to redefine elderly care
Fischer Medical Venture and BluSim Tech partner to redefine elderly care

By IPP Bureau - June 10, 2024

his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio

Neuland unveils refreshed brand identity
Neuland unveils refreshed brand identity

By IPP Bureau - June 10, 2024

The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress

Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing
Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing

By IPP Bureau - June 09, 2024

DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,

Latest Stories

Interviews

Packaging